Neil Herskowitz, Director at Innovive Pharmaceuticals, Inc. (IVPH.OB), bought 18,315 shares at $2.73 ($50K) on 2007-04-24, disclosed to the SEC on 2007-04-26.
Open-market purchase of $50k IVPH.OB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ATXI | BUY | 2021-05-07 | $10K | — | Filing → |
| ATXI | BUY | 2020-03-02 | $21K | — | Filing → |
| ATXI | BUY | 2020-02-25 | $93K | — | Filing → |